Patents Assigned to GENEXPRESS INFORMATICS
  • Publication number: 20120022377
    Abstract: The disclosure is directed to a transcranial Doppler probe. The transcranial Doppler probe includes a spherical bearing, a piezoelectric transducer pivotally attached to the spherical bearing, and first and second rods coupled to the piezoelectric transducer. The first rod is configured to pivot the piezoelectric transducer around a first pivot axis and the second rod is configured to pivot the piezoelectric transducer around a second pivot axis.
    Type: Application
    Filed: July 13, 2011
    Publication date: January 26, 2012
    Applicant: GENEXPRESS INFORMATICS, INC.
    Inventors: Robert C. Chin, Sridhar Madala, Graham Patrick Sattler
  • Publication number: 20080311677
    Abstract: A method of detecting a target substance includes contacting the target substance with a substrate. The substrate has a first receptor bound to the substrate. The target substance binds to the first receptor. The method further includes contacting a second receptor with the substrate. The second receptor is associated with the target substance. The second receptor is biotinylated. The method also includes contacting an anti-biotin antibody conjugated paramagnetic particle with the substrate.
    Type: Application
    Filed: March 12, 2008
    Publication date: December 18, 2008
    Applicant: GENEXPRESS INFORMATICS
    Inventors: Robert C. Chin, Gregory F. Lopreato
  • Patent number: 6861219
    Abstract: There is a tremendous need for high throughput gene expression technology which can efficiently and cheaply identify and accurately isolate different genes expressed between diseased and normal tissues for use in discovering new drugs. The present invention utilizes a combination of biomolecular chemistry methods to eliminate/degrade redundant sequences and fluorescence dye assay to identify these unique sequences from two cell or tissue populations. cDNA from normal or diseased cells or tissues are hybridized with the RNA of the complement normal or diseased cells or tissues. The hybridized cDNA/RNA is incubated with exonucleases, resulting in degradation of all but the single stranded RNA and DNA. RNA are then eliminated using RNase and the remaining DNA which are unique to the sample are amplified.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: March 1, 2005
    Assignee: Genexpress Informatics, Inc.
    Inventors: Shahzi Iqbal, Robert Chin